20/20 Biolabs Inc. Common Stock (AIDX)
Stock · NASDAQ · Health Care
$0.62as of 8/28/2026
Price chart
Open in TradingViewAbout AIDX
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups.…
- Sector
- Health Care
- Industry
- Precision Instruments
- Employees
- 4
- Website
- 2020gene.com/
Fundamentals
- 1-day range
- $0.615$0.67
- Market cap
- $5.22M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.49
- Dividend yield
- —
- Beta
- 2.40
- Avg. volume
- 644.9K
52-week range
$0.4011$50
Forecasts
1 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$5
+706.5%
Median
$5
+706.5%
Low
$5
+706.5%
20/20 Biolabs Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AIDX20/20 Biolabs Inc. Common Stock$0.6598▲ 6.42%Market cap $5.22MP/E —$0.4011$50
- NDRAENDRA Life Sciences Inc. Common Stock$5.16▼ 4.63%Market cap $5.19MP/E —$2.96$9.85
- LABTLakewood-Amedex Biotherapeutics Inc. Common Stock$2.3▼ 4.56%Market cap $5.28MP/E —$0.366$9.82
- GOVXGeoVax Labs Inc. Common Stock$0.7195▲ 0.35%Market cap $5.34MP/E —$0.59$19.2
- BGMSBio Green Med Solution Inc. Common Stock$0.86▼ 3.37%Market cap $5.35MP/E 0.18$0.5664$8.82
- BRTXBioRestorative Therapies Inc. Common Stock (NV)$0.199▼ 3.40%Market cap $5.04MP/E —$0.1593$1.89
- BCABBioAtla Inc. Common Stock$1.79▼ 42.99%Market cap $5.41MP/E —$2.81$71.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AIDX 20/20 Biolabs Inc. Common Stock | $5.22M | — | $0.6598 | ▲ 6.42% | $0.4011$50 |
| NDRA ENDRA Life Sciences Inc. Common Stock | $5.19M | — | $5.16 | ▼ 4.63% | $2.96$9.85 |
| LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock | $5.28M | — | $2.3 | ▼ 4.56% | $0.366$9.82 |
| GOVX GeoVax Labs Inc. Common Stock | $5.34M | — | $0.7195 | ▲ 0.35% | $0.59$19.2 |
| BGMS Bio Green Med Solution Inc. Common Stock | $5.35M | 0.18 | $0.86 | ▼ 3.37% | $0.5664$8.82 |
| BRTX BioRestorative Therapies Inc. Common Stock (NV) | $5.04M | — | $0.199 | ▼ 3.40% | $0.1593$1.89 |
| BCAB BioAtla Inc. Common Stock | $5.41M | — | $1.79 | ▼ 42.99% | $2.81$71.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial OpportunityYahoo · 8/28/2026
- 20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial OpportunityYahoo · 8/26/2026
- 20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K Estimatebenzinga · 8/17/2026
- 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly LevelYahoo · 8/17/2026
- 20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K EstimateBenzinga · 8/17/2026
Insider Activity
Insider Actions →Acquired
250.0K
Disposed
0
- Bergman Alan B. · April 2, 2026 · Grant100.0K
- Zhou Jiming · April 2, 2026 · Grant150.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 300.4K
- Total value held
- $564.8K
- Institutional holders
- 7
Top holders this quarter
- Unknown264.4K
- Unknown16.2K
- Unknown10.3K
- Unknown8.3K
- Unknown1.0K
- Unknown157
- Unknown30
See the full, filterable feed with live charts on the MarketWall dashboard.